Sort
48,018 grants matching “immunotherapy”
Breaking down tumor immune privilege through targeted hypoxia reduction
$481,691Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
NCI Moonshot: Pediatric Core
$481,675Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$481,659Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
NIH Chronic GVHD Study Group
$481,641Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Novel IL-12 Gene Delivery Vehicles for Transformation of Solid Tumors
$481,578Seth M Pollack · Northwestern University At Chicago · R01 · FY2023 · CA
Generating CTL Against Tumor Associated Peptide Antigens
$481,518Linda A Sherman · Scripps Research Institute, The · R01 · FY2007 · CA
Renalase inhibition for treatment of unresectable melanoma
$481,477Harriet M Kluger · Yale University · R01 · FY2021 · CA
Targeting HSP70 for Melanoma Therapy
$481,458Maureen E Murphy · Wistar Institute · P01 · FY2019 · CA
Molecular Mechanisms Underlying Dendritic Cell Adaptations During Chronic Infection
$481,406Elina I Zuniga · University Of California, San Diego · R01 · FY2021 · AI
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$481,349Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
JAML: A New Costimulatory Molecule for Gamma Delta T Cells
$481,250Wendy L Havran · Scripps Research Institute, The · R01 · FY2016 · AI
Enhancing the Immunogenicity of Recombinant MVA Vectors
$481,191Emory University · U19 · FY2004 · AI
Project 1: FLASH vs. Standard radiotherapy for treatment of PDAC and sparing normal intestine tissues
$481,131Constantinos Koumenis · University Of Pennsylvania · P01 · FY2022 · CA
Regulation of encephalitogenic T cells by CRAC channels
$481,126Stefan Feske · New York University School Of Medicine · R01 · FY2018 · AI
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation
$481,066Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2025 · CA
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
$481,065Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Targeting PPT1 in the Tumor Microenvironment
$480,986Ravi K Amaravadi · Wistar Institute · P01 · FY2022 · CA
Developing newly combined therapeutic strategies for mature B cell lymphoma
$480,946Jing Hong Wang · University Of Colorado Denver · R01 · FY2019 · CA
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$480,895Periasamy Selvaraj · Emory University · R01 · FY2020 · CA
Gonorrhea and HIV prevention with intravaginal ring drug delivery
$480,773Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R33 · FY2020 · AI
Molecular Mechanisms Underlying Dendritic Cell Adaptations During Chronic Infection
$480,770Elina I Zuniga · University Of California, San Diego · R01 · FY2020 · AI
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
$480,760Ralph P Mason · Ut Southwestern Medical Center · R01 · FY2023 · CA
Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors
$480,710Karen M Cichowski · Brigham And Women'S Hospital · U01 · FY2022 · CA
Data Management and Analysis Core
$480,706Aris Floratos · Columbia University Health Sciences · U19 · FY2019 · AI
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$480,703Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2023 · CA